Insys Therapeutics beats by $0.10, misses on revenue

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Insys Therapeutics (INSY): Q1 EPS of $0.41 beats by $0.10.

Revenue of $41.6M (+276.1% Y/Y) misses by $4.03M.